Status Update
Logotype for 111 Inc

111 (YI) Status Update summary

Event summary combining transcript, slides, and related documents.

Logotype for 111 Inc

Status Update summary

17 Jan, 2026

Key challenges in China's pharmaceutical supply chain

  • Market fragmentation with thousands of companies and distributors limits scale and efficiency.

  • Lack of digitization and transparency creates friction and inefficiencies.

  • Limited supply chain optimization leads to excess stock and high stock-out rates.

Technology and operational solutions

  • Over 30 proprietary systems developed for supply chain management, including demand forecasting and price intelligence.

  • Innovations have reduced procurement costs from over 5% to 2.6% of revenue in five years.

  • Digital tools extend to partners, providing visibility and optimization for both upstream and downstream stakeholders.

Fulfillment network scale and models

  • Operates 13 fulfillment centers, including five super hubs in major cities, covering all of China.

  • Uses a mix of self-built, partner-transformed, and franchise models, all with standardized systems and quality control.

  • New fulfillment centers reduce setup time by 70% through partnerships.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more